Funder
Cantab Anti-infectives Ltd
National Institute of Allergy and Infectious Diseases
National Institutes of Health
Department of Health and Human Services
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference19 articles.
1. Prioritisation of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections including tuberculosis. Geneva: World Health Organisation; 2017(WHO/EKP/IAU/2017.12).
2. Resurgence of polymyxin B for MDR/XDR gram-negative infections: an overview of current evidence.;Garg;Crit Care Res Pract,2017
3. Agents of last resort: polymyxin resistance;Kaye;Infect Dis Clin N Am,2016
4. Interactions of lipopolysaccharide and polymyxin studied by NMR spectroscopy;Mares;J Biol Chem,2009
5. In vitro potency of various Polymyxin B components;Tam;Antimicrob Agents Chemother,2011
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献